Czechia· CZ-0254405

BRUFEN

A ibuprofen product, registered in Czechia by Mylan IRE Healthcare Limited, Dublin. The same ATC class is registered in 12 of our 19 countries.

ATC M01AE01

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedBRUFENATCM01AE01REGISTER NO.CZ-0254405PACKS LISTED0CHECKEDJune 22, 2026

Where it is registered

Ibuprofen is registered in 12 of 19 countries.

Countries holding a registration under ATC M01AE01 (ibuprofen), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 8 of them publish a price we can compare per daily dose

Ibuprofen · ATC M01AE01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ibuprofen costs, country by country.

Normalised to the WHO defined daily dose (1.2 g), the median price runs from $0.28 in Italy to $1.24 in Switzerland — a ×4.4 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Ibuprofen · price per daily dose (1.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.24
  • IT Italy$0.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

SÚKL (Czech Republic)
Manufacturer
Mylan IRE Healthcare Limited, Dublin
Country
Czechia (CZ)
ATC code
M01AE01
ATC class
Ibuprofen
Defined daily dose
1.2 g, O
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
June 22, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

886 interactions on record for ibuprofen.

Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ibuprofen · interactions on record

886 records

  • 71 severe
  • 306 moderate
  • 15 minor
  • 413 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f106cc3f-0210-4373-bec6-22110d671a6b
GET /v1/drugs/f106cc3f-0210-4373-bec6-22110d671a6b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL FLM",
  "source": "sukl",
  "strength": "400MG",
  "pack_size": "50 I",
  "substance": "1593",
  "cz_kod_sukl": "0254405",
  "product_type": "CH",
  "registration_state": "B",
  "registration_number": "29/390/92-S/C"
}

See everything about ibuprofen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.